Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

home_office

UK Home office reclassifies Epidyolex as a Schedule 5 drug

June 24, 2020 Research and Development CBD, cannabiodiol, cannabis

The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …
News
gilead-sciences

Gilead to investigate inhaled formulation of promising COVID-19 therapy remdesivir

June 23, 2020 Manufacturing and Production, Research and Development COVID-19, Gilead, remdesivir

Gilead is intent on pushing the applications of its antiviral drug remdesivir after it has shown efficacy in the treatment …
News
pexels-photo-3044623_araruna

How is COVID-19 impacting the rare disease community?

June 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
Feature
shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …
News

Roche’s Tecentriq improves pathological complete response in triple-negative breast cancer at Phase 3

June 19, 2020 Medical Communications, Research and Development Cancer, Genentech, Roche, breast cancer, tecentriq

 
News
lilly_building_with_american_flag_web

Lilly’s Verzenio combo tops Pfizer’s Ibrance and is first CDK4/6 inhibitor to show benefit in HR+,HER2- early breast cancer

June 18, 2020 Research and Development Eli Lilly, Pfizer, Verzenio, breast cancer, ibrance

 
News

Roche’s rheumatoid arthritis drug Actemra shows no benefit in COVID-19 pneumonia

June 18, 2020 Research and Development Actemra, COVID-19, Roche, coronavirus

Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing …
News

FDA approval for Jazz and PharmaMar’s Zepzelca in metastatic small cell lung cancer

June 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, FDA, PharmaMar, Zepzelca, jazz pharma, lung cancer

The FDA has awarded approval to Jazz Pharma and PharmaMar for Zepzelca (lurbinectedin) as a treatment for metastatic small cell …
News
type_2

New data from diabetes prevention programme shows a reduction of type 2 diabetes

June 17, 2020 Research and Development diabetes, type 2 diabetes

The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …
News
dexamethasone_matthew_horwoodgetty_images

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

June 17, 2020 Research and Development COVID-19, University of Oxford, coronavirus, dexamethasone

The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 17, 2020 Research and Development COVID-19, coronavirus, coronavirus roundup

There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest …
News

HPV vaccine approved by FDA to prevent throat cancer

June 17, 2020 Research and Development HPV, HPV STI, HPV vaccine

The HPV (human papillomavirus) vaccine Gardasil 9 has been approved by the FDA to prevent HPV-related genital tract, agnogenital infections …
News
sinovac

Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2

June 16, 2020 Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …
News
marc_p2

Mundipharma names Marc Princen as Global Chief Executive Officer

June 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …
Appointment
covid-19-4922384_640

COVID-19: UK and Europe life sciences regulatory developments

June 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …
Feature
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026